108th Congress / Bills / H R 2122

Title

To enhance research, development, procurement, and use of biomedical countermeasures to respond to public health threats affecting national security, and for other purposes.

Read more information on this bill at the Library of Congress.

Categories (What are categories?)

Administrative procedure | Armed forces | Authorization | Biological warfare | Black colleges | Budgets | Business | Business records | Chemical warfare | Child health | Children | Clinical trials | Congress | Congressional investigations | Congressional reporting requirements | Consumers | Counterterrorism | Criminal justice | Defense economics | Defense policy | Department of Health and Human Services | Drug approvals | Drug industry | Drugs | EBB Terrorism | Education | Emergency management | Emergency medicine | Employee selection | Executive departments | Export controls | Federal aid to research | Federal employees | Foreign policy | Government contractors | Government employees | Government information | Government paperwork | Government procurement | Government publicity | Government service contracts | Health policy | Higher education | Informed consent (Medical law) | Intelligence activities | Intelligence services | International affairs | Labeling | Laboratories | Law | Licenses | Medical care | Medical fees | Medical instruments and apparatus | Medical laboratories | Medical records | Medical research | Medical supplies | Medicine | Military medicine | Military personnel | Minorities | Minority education | National security | Nuclear terrorism | Peer review organizations (Medicine) | Pharmaceutical research | Prescription pricing | Product safety | Public contracts | Public health | Research and development | Research and development facilities | Research grants | Science policy | Security measures | Smallpox | Storage | Strategic materials | Technological innovations | Technology | Terrorism | Trade | Vaccines | Weapons systems

Votes on this bill